SOCS5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.526600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.672560E-01
Normal-vs-Stage2
6.000200E-01
Normal-vs-Stage3
4.649200E-01
Normal-vs-Stage4
5.759400E-01
Stage1-vs-Stage2
4.653200E-01
Stage1-vs-Stage3
7.951600E-01
Stage1-vs-Stage4
6.090000E-02
Stage2-vs-Stage3
7.277600E-01
Stage2-vs-Stage4
2.144600E-01
Stage3-vs-Stage4
2.367000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.207000E-01
Normal-vs-AfricanAmerican
9.787000E-01
Normal-vs-Asian
1.539570E-01
Caucasian-vs-AfricanAmerican
4.020000E-01
Caucasian-vs-Asian
2.543200E-01
AfricanAmerican-vs-Asian
1.618200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.543600E-01
Normal-vs-Female
5.673400E-01
Male-vs-Female
6.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.441400E-01
Normal-vs-Age(41-60Yrs)
9.366800E-01
Normal-vs-Age(61-80Yrs)
4.531000E-01
Normal-vs-Age(81-100Yrs)
8.791900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.438200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.768200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.571600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.887790E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.675600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.297000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.549600E-01
Normal-vs-Daily Drinker
1.364590E-01
Normal-vs-Weekly Drinker
6.812600E-01
Normal-vs-Occasional Drinker
6.942400E-01
Normal-vs-Social Drinker
9.624800E-01
Non Drinker-vs-Daily Drinker
5.980200E-01
Non Drinker-vs-Weekly Drinker
2.305600E-01
Non Drinker-vs-Occasional Drinker
1.839970E-01
Non Drinker-vs-Social Drinker
1.681390E-01
Daily Drinker-vs-Weekly Drinker
1.083590E-01
Daily Drinker-vs-Occasional Drinker
8.260400E-02
Daily Drinker-vs-Social Drinker
1.049990E-01
Weekly Drinker-vs-Occasional Drinker
9.733200E-01
Weekly Drinker-vs-Social Drinker
5.672200E-01
Occasional Drinker-vs-Social Drinker
5.664600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.881360E-01
Normal-vs-Grade 2
3.251600E-02
Normal-vs-Grade 3
8.534100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.109600E-02
Grade 1-vs-Grade 3
1.132400E-01
Grade 1-vs-Grade 4
1.881360E-01
Grade 2-vs-Grade 3
9.025800E-01
Grade 2-vs-Grade 4
3.251600E-02
Grade 3-vs-Grade 4
8.534100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.225200E-01
Normal-vs-NonDiabetic
4.833200E-01
Diabetic-vs-NonDiabetic
8.003400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.126800E-01
Normal-vs-NoPancreatitis
5.567200E-01
Pancreatitis-vs-NoPancreatitis
5.384200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.422400E-01
Normal-vs-N1
6.403000E-01
N0-vs-N1
1.726650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.498000E-01
Normal-vs-TP53-NonMutant
3.614800E-01
TP53-Mutant-vs-TP53-NonMutant
6.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
